All 1 tracked stories fall under one category: pharma. Evercore 2nd China Biotech Summit is most often covered alongside ATG-022, which appears in 1 of these 1 story. Evercore 2nd China Biotech Summit appears in 1 tracked Biotech story from August 23, 2026.
Recent coverage · Evercore 2nd China Biotech Summit
1story
avg impact
0%positive
0%negative
100% neutral
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Evercore 2nd China Biotech Summit
All 1 tracked stories fall under one category: pharma. Evercore 2nd China Biotech Summit is most often covered alongside ATG-022, which appears in 1 of these 1 story. Evercore 2nd China Biotech Summit appears in 1 tracked Biotech story from August 23, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Evercore 2nd China Biotech Summit. Shared-story counts are live from our verified record — not editorial picks.
For biotech and pharma professionals, Antengene's showcase demonstrates platform depth in T-cell engager engineering, adding TriGager to its AnTenGager toolbox and introducing a first-in-class αCD3-TGF-β fusion protein. The presentation also included updated ATG-022 data, though no quantitative results were disclosed. This positions Antengene as a company to watch in the crowded CLDN18.2 and TCE arenas.
Evercore 2nd China Biotech Summit is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.
